In this issue
Risk factors for mortality, hospitalisation and imprisonment in substance misuse patientsSubscription
Pharmacists should be aware of the mortality rates and adverse outcomes, including hospitalisation and imprisonment, that are rife in illicit drug users and patients on opioid substitution therapy, in order to optimise patient safety and reduce adverse outcomes.
By using Oncotype DX test technology, researchers behind the TAILORx trial have proven that invasive and often harmful chemotherapy needn’t be the only option for women with breast cancer.
An overview of management options for type 1 diabetes, the types of insulin, insulin regimens and strengths available for its day-to-day management as well as how to adjust doses and the role of carbohydrate counting and blood glucose monitoring.
Research in practice has traditionally been the Cinderella of academia. Many pharmacists conduct service evaluations and audits, but often the findings are not published.